FRESENIUS MEDICAL CARE AG (FME.DE) Fundamental Analysis & Valuation

FRA:FME • DE0005785802

Current stock price

40.27 EUR
+0.34 (+0.85%)
Last:

This FME.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. FME.DE Profitability Analysis

1.1 Basic Checks

  • FME had positive earnings in the past year.
  • FME had a positive operating cash flow in the past year.
  • In the past 5 years FME has always been profitable.
  • Each year in the past 5 years FME had a positive operating cash flow.
FME.DE Yearly Net Income VS EBIT VS OCF VS FCFFME.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.16%, FME is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • With a Return On Equity value of 7.35%, FME perfoms like the industry average, outperforming 57.58% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 5.30%, FME is in line with its industry, outperforming 54.55% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for FME is below the industry average of 6.44%.
  • The 3 year average ROIC (4.02%) for FME is below the current ROIC(5.30%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROIC 5.3%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
FME.DE Yearly ROA, ROE, ROICFME.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • FME has a better Profit Margin (4.98%) than 78.79% of its industry peers.
  • FME's Profit Margin has declined in the last couple of years.
  • FME has a Operating Margin of 9.00%. This is in the better half of the industry: FME outperforms 66.67% of its industry peers.
  • In the last couple of years the Operating Margin of FME has declined.
  • With a decent Gross Margin value of 25.62%, FME is doing good in the industry, outperforming 60.61% of the companies in the same industry.
  • FME's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9%
PM (TTM) 4.98%
GM 25.62%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
FME.DE Yearly Profit, Operating, Gross MarginsFME.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. FME.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FME is destroying value.
  • The number of shares outstanding for FME has been reduced compared to 1 year ago.
  • Compared to 5 years ago, FME has less shares outstanding
  • Compared to 1 year ago, FME has a worse debt to assets ratio.
FME.DE Yearly Shares OutstandingFME.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
FME.DE Yearly Total Debt VS Total AssetsFME.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 2.24 indicates that FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • FME's Altman-Z score of 2.24 is fine compared to the rest of the industry. FME outperforms 63.64% of its industry peers.
  • The Debt to FCF ratio of FME is 6.19, which is on the high side as it means it would take FME, 6.19 years of fcf income to pay off all of its debts.
  • FME has a better Debt to FCF ratio (6.19) than 75.76% of its industry peers.
  • FME has a Debt/Equity ratio of 0.65. This is a neutral value indicating FME is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.65, FME is in the better half of the industry, outperforming 78.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Altman-Z 2.24
ROIC/WACC0.9
WACC5.88%
FME.DE Yearly LT Debt VS Equity VS FCFFME.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.3 Liquidity

  • FME has a Current Ratio of 1.26. This is a normal value and indicates that FME is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of FME (1.26) is better than 66.67% of its industry peers.
  • A Quick Ratio of 0.92 indicates that FME may have some problems paying its short term obligations.
  • FME has a Quick ratio (0.92) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.92
FME.DE Yearly Current Assets VS Current LiabilitesFME.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. FME.DE Growth Analysis

3.1 Past

  • FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.00%, which is quite impressive.
  • FME shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.51% yearly.
  • Looking at the last year, FME shows a small growth in Revenue. The Revenue has grown by 1.51% in the last year.
  • Measured over the past years, FME shows a small growth in Revenue. The Revenue has been growing by 1.91% on average per year.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%

3.2 Future

  • FME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.03% yearly.
  • FME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.69% yearly.
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue Next Year0.74%
Revenue Next 2Y2.42%
Revenue Next 3Y2.64%
Revenue Next 5Y3.69%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FME.DE Yearly Revenue VS EstimatesFME.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FME.DE Yearly EPS VS EstimatesFME.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

5

4. FME.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.39, the valuation of FME can be described as very reasonable.
  • 93.94% of the companies in the same industry are more expensive than FME, based on the Price/Earnings ratio.
  • FME is valuated cheaply when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 10.04, the valuation of FME can be described as reasonable.
  • 87.88% of the companies in the same industry are more expensive than FME, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.12, FME is valued rather cheaply.
Industry RankSector Rank
PE 9.39
Fwd PE 10.04
FME.DE Price Earnings VS Forward Price EarningsFME.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FME is on the same level as its industry peers.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as FME.
Industry RankSector Rank
P/FCF 13.55
EV/EBITDA 9.77
FME.DE Per share dataFME.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.07%
EPS Next 3Y6.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. FME.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.62%, FME has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.69, FME pays a better dividend. On top of this FME pays more dividend than 96.97% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, FME pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.62%

5.2 History

  • The dividend of FME has a limited annual growth rate of 4.43%.
Dividend Growth(5Y)4.43%
Div Incr Years1
Div Non Decr Years2
FME.DE Yearly Dividends per shareFME.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • FME pays out 43.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.19%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
FME.DE Yearly Income VS Free CF VS DividendFME.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
FME.DE Dividend Payout.FME.DE Dividend Payout, showing the Payout Ratio.FME.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FME.DE Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS MEDICAL CARE AG

FRA:FME (3/17/2026, 7:00:00 PM)

40.27

+0.34 (+0.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners44.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.63B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target45.79 (13.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.62%
Yearly Dividend1.48
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)-0.01%
PT rev (3m)-4.33%
EPS NQ rev (1m)30.45%
EPS NQ rev (3m)95.67%
EPS NY rev (1m)-3.3%
EPS NY rev (3m)-3.16%
Revenue NQ rev (1m)-5.25%
Revenue NQ rev (3m)-4.55%
Revenue NY rev (1m)-2.09%
Revenue NY rev (3m)-2.06%
Valuation
Industry RankSector Rank
PE 9.39
Fwd PE 10.04
P/S 1.2
P/FCF 13.55
P/OCF 8.81
P/B 1.78
P/tB N/A
EV/EBITDA 9.77
EPS(TTM)4.29
EY10.65%
EPS(NY)4.01
Fwd EY9.96%
FCF(TTM)2.97
FCFY7.38%
OCF(TTM)4.57
OCFY11.35%
SpS33.45
BVpS22.68
TBVpS-2.58
PEG (NY)N/A
PEG (5Y)N/A
Graham Number46.79
Profitability
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROCE 7.13%
ROIC 5.3%
ROICexc 5.78%
ROICexgc 16.63%
OM 9%
PM (TTM) 4.98%
GM 25.62%
FCFM 8.88%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Debt/EBITDA 2.64
Cap/Depr 62.47%
Cap/Sales 4.78%
Interest Coverage 4.9
Cash Conversion 82.09%
Profit Quality 178.22%
Current Ratio 1.26
Quick Ratio 0.92
Altman-Z 2.24
F-Score8
WACC5.88%
ROIC/WACC0.9
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year0.74%
Revenue Next 2Y2.42%
Revenue Next 3Y2.64%
Revenue Next 5Y3.69%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year72.47%
EBIT Next 3Y24.27%
EBIT Next 5Y15.34%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%

FRESENIUS MEDICAL CARE AG / FME.DE Fundamental Analysis FAQ

What is the fundamental rating for FME stock?

ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.


What is the valuation status for FME stock?

ChartMill assigns a valuation rating of 5 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for FRESENIUS MEDICAL CARE AG?

FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 5 / 10.


What is the valuation of FRESENIUS MEDICAL CARE AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 9.39 and the Price/Book (PB) ratio is 1.78.


How sustainable is the dividend of FRESENIUS MEDICAL CARE AG (FME.DE) stock?

The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 43.19%.